产品说明 包装 1, 5 mg in glass bottle 生化/生理作用 Selective TP prostanoid receptor antagonist. Inhibits U-46619-induced contraction of guinea pig trachea with IC50=1.8 nM. 特点和优势 This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is featured on the Prostanoid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. 法律信息 Manufactured and sold under agreement from GlaxoSmithKline 基本信息 | 经验(实验)分子式 | C30H40NO4Cl | | 分子量 | 514.10 | | MDL编号 | MFCD04113055 | | PubChem化学物质编号 | 329799744 | | NACRES | NA.77 |
产品性质 | 质量水平 | 100 | | 测定 | ≥98% (HPLC) | | 形式 | solid | | 颜色 | off-white | | mp | 127-128 ℃ | | 溶解性 | H2O: ~16 mg/mL | | 创始人 | GlaxoSmithKline | | 运输 | wet ice | | 储存温度 | −20℃ | | SMILES string | Cl.O[C@H]1C[C@H](OCc2ccc(cc2)-c3ccccc3)[C@H](CC\C=C/CCC(O)=O)[C@H]1N4CCCCC4 | | InChI | 1S/C30H39NO4.ClH/c32-27-21-28(35-22-23-15-17-25(18-16-23)24-11-5-3-6-12-24)26(13-7-1-2-8-14-29(33)34)30(27)31-19-9-4-10-20-31;/h1-3,5-6,11-12,15-18,26-28,30,32H,4,7-10,13-14,19-22H2,(H,33,34);1H/b2-1-;/t26-,27-,28-,30+;/m0./s1 | | InChI key | ZYOBZRTZRQKKNC-UGNABIHOSA-N |
安全信息 | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Gloves, type N95 (US) |
|
m.cnreagent.com